QQQ   432.22 (+0.27%)
AAPL   169.35 (-1.93%)
MSFT   416.39 (+0.66%)
META   502.86 (+0.53%)
GOOGL   154.69 (-0.11%)
AMZN   184.02 (+0.22%)
TSLA   157.92 (-2.20%)
NVDA   875.30 (+1.78%)
AMD   163.71 (+2.11%)
NIO   3.84 (-1.29%)
BABA   70.00 (-0.88%)
T   16.07 (-1.05%)
F   12.19 (-0.33%)
MU   121.40 (+0.02%)
GE   155.60 (+1.24%)
CGC   6.89 (-1.29%)
DIS   114.10 (+1.02%)
AMC   2.73 (+10.53%)
PFE   25.86 (-0.19%)
PYPL   63.99 (+0.76%)
XOM   118.92 (-0.64%)
QQQ   432.22 (+0.27%)
AAPL   169.35 (-1.93%)
MSFT   416.39 (+0.66%)
META   502.86 (+0.53%)
GOOGL   154.69 (-0.11%)
AMZN   184.02 (+0.22%)
TSLA   157.92 (-2.20%)
NVDA   875.30 (+1.78%)
AMD   163.71 (+2.11%)
NIO   3.84 (-1.29%)
BABA   70.00 (-0.88%)
T   16.07 (-1.05%)
F   12.19 (-0.33%)
MU   121.40 (+0.02%)
GE   155.60 (+1.24%)
CGC   6.89 (-1.29%)
DIS   114.10 (+1.02%)
AMC   2.73 (+10.53%)
PFE   25.86 (-0.19%)
PYPL   63.99 (+0.76%)
XOM   118.92 (-0.64%)
QQQ   432.22 (+0.27%)
AAPL   169.35 (-1.93%)
MSFT   416.39 (+0.66%)
META   502.86 (+0.53%)
GOOGL   154.69 (-0.11%)
AMZN   184.02 (+0.22%)
TSLA   157.92 (-2.20%)
NVDA   875.30 (+1.78%)
AMD   163.71 (+2.11%)
NIO   3.84 (-1.29%)
BABA   70.00 (-0.88%)
T   16.07 (-1.05%)
F   12.19 (-0.33%)
MU   121.40 (+0.02%)
GE   155.60 (+1.24%)
CGC   6.89 (-1.29%)
DIS   114.10 (+1.02%)
AMC   2.73 (+10.53%)
PFE   25.86 (-0.19%)
PYPL   63.99 (+0.76%)
XOM   118.92 (-0.64%)
QQQ   432.22 (+0.27%)
AAPL   169.35 (-1.93%)
MSFT   416.39 (+0.66%)
META   502.86 (+0.53%)
GOOGL   154.69 (-0.11%)
AMZN   184.02 (+0.22%)
TSLA   157.92 (-2.20%)
NVDA   875.30 (+1.78%)
AMD   163.71 (+2.11%)
NIO   3.84 (-1.29%)
BABA   70.00 (-0.88%)
T   16.07 (-1.05%)
F   12.19 (-0.33%)
MU   121.40 (+0.02%)
GE   155.60 (+1.24%)
CGC   6.89 (-1.29%)
DIS   114.10 (+1.02%)
AMC   2.73 (+10.53%)
PFE   25.86 (-0.19%)
PYPL   63.99 (+0.76%)
XOM   118.92 (-0.64%)
Free Trial

Zevra Therapeutics (ZVRA) Insider Trading & Ownership

→ This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad)
Free ZVRA Stock Alerts
$4.87
+0.08 (+1.67%)
(As of 12:57 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Zevra Therapeutics (NASDAQ:ZVRA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
2.40%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$133,682.25
Number Of
Insiders Selling
(Last 12 Months)
0
Get ZVRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Zevra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ZVRA Insider Buying and Selling by Quarter

Ad Darwin
Your Next Portfolio Star: Revealing 2024's Top Stock Pick
We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)
Click here to download your report

Zevra Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2023R. Laduane CliftonCFOBuy1,000$4.96$4,960.00  
9/5/2023John B BodeDirectorBuy10,000$5.13$51,300.00  
9/5/2023Joshua SchaferEVPBuy500$5.13$2,565.00  
6/23/2023Corey Michael WattonDirectorBuy275$5.95$1,636.25  
6/9/2023Corey Michael WattonDirectorBuy325$5.52$1,794.00  
5/30/2023Corey Michael WattonDirectorBuy400$5.11$2,044.00  
5/19/2023Joshua SchaferEVPBuy1,000$5.42$5,420.00  
5/18/2023John B BodeDirectorBuy10,000$5.04$50,400.00  
5/18/2023R. Laduane CliftonCFOBuy2,740$4.95$13,563.00  
(Data available from 1/1/2013 forward)

ZVRA Insider Trading Activity - Frequently Asked Questions

Who is on Zevra Therapeutics's Insider Roster?

The list of insiders at Zevra Therapeutics includes Corey Michael Watton, John B Bode, Joshua Schafer, Matthew R Plooster, R. Laduane Clifton, Richard W Pascoe, Tamara A Seymour, and Timothy J Sangiovanni. Learn more on insiders at ZVRA.

What percentage of Zevra Therapeutics stock is owned by insiders?

2.40% of Zevra Therapeutics stock is owned by insiders. Learn more on ZVRA's insider holdings.

Which Zevra Therapeutics insiders have been buying company stock?

The following insiders have purchased ZVRA shares in the last 24 months: Corey Michael Watton ($5,474.25), John B Bode ($101,700.00), Joshua Schafer ($17,205.00), Matthew R Plooster ($46,200.00), R. Laduane Clifton ($25,681.75), Richard W Pascoe ($42,000.00), Tamara A Seymour ($2,501.58), and Timothy J Sangiovanni ($4,968.00).

How much insider buying is happening at Zevra Therapeutics?

Insiders have purchased a total of 52,684 ZVRA shares in the last 24 months for a total of $245,730.58 bought.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:ZVRA) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency